Table 1.
Demographics | Ketoconazole study | Rifampin study | Midazolam study | Verapamil study | Digoxin study |
---|---|---|---|---|---|
Subjects completing the study (n) | 11 | 24 | 22 | 20 | 23 |
Male/female (n) | 7/4 | 17/7 | 21/1 | 15/5 | 15/8 |
Age (years) | 30 (20–42) | 31 (18–45) | 33 (19–44) | 29 (19–43) | 32 (18–45) |
Race | |||||
Black | 0 | 4 | 0 | 1 | 1 |
Caucasian | 11 | 20 | 22 | 18 | 22 |
Hispanic | 0 | 0 | 0 | 0 | 0 |
Other | 0 | 0 | 0 | 1 | 0 |
Height (cm) | 167.0 | 172.0 | 172.1 | 174.2 | 168.5 |
(149.0–180.5) | (152.5–190.0) | (155.5–189.0) | (160.0–193.5) | (153.0–183.5) | |
Weight (kg) | 66.3 | 74.3 | 75.3 | 76.9 | 68.7 |
(45.3–92.1) | (56.8–98.8) | (58.2–102.0) | (56.9–103.5) | (55.4–89.1) | |
Body mass index (kg m−2) | 23.5 | 25.0 | 25.4 | 25.2 | 24.2 |
(19.8–29.6) | (20.7–29.3) | (20.6–29.3) | (19.1–28.8) | (20.6–27.4) |
Values are shown as means (range).